Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed refractory low-grade glioma.

被引：13
|
作者：
Kieran, Mark W.
Bouffet, Eric
Broniscer, Alberto
Cohen, Kenneth J.
Geoerger, Birgit
Hansford, Jordan R.
Hingorani, Pooja
Aerts, Isabelle
Andre, Nicolas
Bertozzi-Salamon, Anne-Isabelle
Dunkel, Ira J.
Hummel, Trent Ryan
Leary, Sarah
Moreno, Lucas
Russo, Mark W.
Tseng, Lillian
Dasgupta, Kohinoor
Nebot, Noelia
Whitlock, James
Hargrave, Darren R.
机构：
[1] Harvard Med Sch, Boston Childrens Hosp, Dana Farber Canc Inst, Boston, MA USA
[2] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada
[3] St Jude Childrens Res Hosp, Memphis, TN USA
[4] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[5] Univ Paris Sud, Gustave Roussy Dept Childhood & Adolescent Oncol, Villejuif, France
[6] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Melbourne, Australia
[7] Phoenix Childrens Hosp, Phoenix, AZ USA
[8] PSL Res Univ, Inst Curie, Oncol Ctr SIREDO, Paris, France
[9] Aix Marseille Univ, Childrens Hosp La Timone, AP HM, Marseille, France
[10] CHU Toulouse Pole Pediatr, Toulouse, France
[11] Mem Sloan Kettering Canc Ctr, New York, NY USA
[12] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH USA
[13] Seattle Childrens Hosp, Canc & Blood Disorders Ctr, Seattle, WA USA
[14] Hosp Univ Nino Jesus, Madrid, Spain
[15] Novartis Pharmaceut, E Hanover, NJ USA
[16] Novartis Healthcare Pvt Ltd, Hyderabad, India
[17] Great Ormond St Hosp Sick Children, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.10506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10506
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
    Hargrave, Darren R.
    Bouffet, Eric
    Tabori, Uri
    Broniscer, Alberto
    Cohen, Kenneth J.
    Hansford, Jordan R.
    Geoerger, Birgit
    Hingorani, Pooja
    Dunkel, Ira J.
    Russo, Mark W.
    Tseng, Lillian
    Dasgupta, Kohinoor
    Gasal, Eduard
    Whitlock, James A.
    Kieran, Mark W.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (24) : 7303 - 7311
  • [2] The first study of dabrafenib in pediatric patients with BRAF V600-mutant relapsed or refractory low-grade gliomas
    Kieran, M. W.
    Bouffet, E.
    Tabori, U.
    Broniscer, A.
    Cohen, K.
    Hansford, J.
    Geoerger, B.
    Hingorani, P.
    Dunkel, I.
    Russo, M.
    Tseng, L.
    Liu, Q.
    Nebot, N.
    Whitlock, J.
    Hargrave, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600-Mutant Low-Grade Glioma
    Bouffet, Eric
    Geoerger, Birgit
    Moertel, Christopher
    Whitlock, James A.
    Aerts, Isabelle
    Hargrave, Darren
    Osterloh, Lisa
    Tan, Eugene
    Choi, Jeea
    Russo, Mark
    Fox, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 664 - +
  • [4] Dabrafenib plus trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma: Safety and efficacy results.
    Geoerger, Birgit
    Bouffet, Eric
    Whitlock, James A.
    Moertel, Christopher L.
    Hargrave, Darren R.
    Aerts, Isabelle
    Cohen, Kenneth J.
    Kilburn, Lindsay Baker
    Wright, Karen D.
    Choi, Jeea
    Gasal, Eduard
    Russo, Mark W.
    Fox, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma
    Hargrave, Darren R.
    Terashima, Keita
    Hara, Junichi
    Kordes, Uwe R.
    Upadhyaya, Santhosh A.
    Sahm, Felix
    Bouffet, Eric
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Larissa
    Kieloch, Agnieszka
    Russo, Mark
    Cohen, Kenneth J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5174 - +
  • [6] SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB plus TRAMETINIB (D plus T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH BRAF V600-MUTANT LOW-GRADE GLIOMA (LGG)
    Bouffet, Eric
    Whitlock, James A.
    Moertel, Christopher
    Geoerger, Birgit
    Aerts, Isabelle
    Hargrave, Darren
    Cohen, Kenneth J.
    Kilburn, Lindsay B.
    Upadhyaya, Santhosh A.
    Wetmore, Cynthia
    Wright, Karen D.
    Choi, Jeea
    Gasal, Eduard
    Russo, Mark W.
    Fox, Elizabeth
    [J]. NEURO-ONCOLOGY, 2020, 22 : 375 - 375
  • [7] Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600-mutant high-grade glioma (HGG) or low-grade glioma (LGG)
    Hargrave, D.
    Witt, O.
    Cohen, K.
    Packer, R.
    Lissat, A.
    Kordes, U.
    Laetsch, T. W.
    Hoffman, L.
    Lassaletta, A.
    Gerber, N. U.
    Gilheeney, S.
    Holm, S.
    Kramm, C.
    Sumerauer, D.
    Reitmann, C.
    Russo, M. W.
    Bouffet, E.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 132 - 132
  • [8] EFFICACY AND SAFETY OF DABRAFENIB plus TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED LOW-GRADE GLIOMA (LGG)
    Wen, Patrick
    De Greve, Jacques
    Mason, Warren
    Hofheinz, Ralf-Dieter
    Dietrich, Sascha
    de Vos, Filip
    van den Bent, Martin
    Mookerjee, Bijoyesh
    Boran, Aislyn
    Burgess, Paul
    Rangwala, Fatima
    Gazzah, Anas
    [J]. NEURO-ONCOLOGY, 2018, 20 : 238 - 238
  • [9] UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E-MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)
    Wen, Patrick
    Stein, Alexander
    van den Bent, Martin
    De Greve, Jacques
    Dietrich, Sascha
    De Vos, Filip
    von Bubnoff, Nikolas
    van Linde, Myra
    Lai, Albert
    Prager, Gerald
    Campone, Mario
    Fasolo, Angelica
    Lopez-Martin, Jose
    Kim, Tae Min
    Mason, Warren
    Hofheinz, Ralf-Dieter
    Blay, Jean-Yves
    Cho, Daniel
    Gazzah, Anas
    Gomez-Roca, Carlos
    Yachnin, Jeffrey
    Boran, Aislyn
    Burgess, Paul
    Palanichamy, Ilan
    Gasal, Eduard
    Subbiah, Vivek
    [J]. NEURO-ONCOLOGY, 2019, 21 : 19 - 19
  • [10] Dabrafenib plus trametinib (dab plus tram) in relapsed/refractory (r/r) BRAF V600-mutant pediatric high-grade glioma (pHGG): Primary analysis of a phase II trial.
    Hargrave, Darren R.
    Terashima, Keita
    Hara, Junichi
    Kordes, Uwe R.
    Upadhyaya, Santhosh A.
    Sahm, Felix
    Bouffet, Eric
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Lali
    Kieloch, Agnieszka
    Russo, Mark W.
    Cohen, Kenneth J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345